AVN944

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVN944, covering 2014-01-10 to 2014-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors [NA]